# LACTOSE MONOHYDRATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid301016679
Categories: beauty, pharma
Identifier: DTXSID301016679

> LACTOSE MONOHYDRATE. EPA CPDat observed this chemical in 3 composition records across product categories including Personal care. Assessed from 40 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 3 composition records across product categories including Personal care.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 3 composition records across product categories including Personal care.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 43 mg
- US: inactive ingredient database — Route: INTRACAVERNOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 174 mg
- US: inactive ingredient database — Route: INTRACAVITARY; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 47.5 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 150 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 214 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 150 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 900 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 750 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: 9.5 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 690 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 3990 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED; Maximum daily exposure: 300 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Maximum daily exposure: 265 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 2087 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 5364 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 8946 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Potency: 1691.8 mg/120ml
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: INHALANT; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 640 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 50 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4384 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1412 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 1301 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 2313 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 2575 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 968 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 520 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 2794 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 366 mg
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Maximum daily exposure: 25 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 98 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 214 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 107 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 505 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 586 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: INSERT; Maximum daily exposure: 2282 mg

_Assessed by Greenveil._